Table 3.
Results of interrupted time series regression on patient subgroups.
| % step change in activity at interruption |
% increase in activity per week after interruption |
||||||||
|---|---|---|---|---|---|---|---|---|---|
| Characteristic | Subgroup | % | 95% CI | % | 95% CI | ||||
| All | All | 51.1% | 46.4% | 55.7% | 3.0% | 2.5% | 3.6% | ||
| Sex | male | 51.9% | 46.5% | 57.4% | 3.1% | 2.4% | 3.7% | ||
| female | 50.2% | 45.9% | 54.5% | 2.9% | 2.4% | 3.4% | |||
| age group | 0 to 19 | 69.1% | 54.6% | 85.7% | 2.6% | 0.9% | 4.3% | ||
| 20 to 64 | 47.1% | 41.7% | 52.8% | 3.5% | 2.8% | 4.1% | |||
| 65 to 74 | 42.6% | 37.1% | 48.3% | 3.0% | 2.3% | 3.7% | |||
| 75+ | 40.1% | 35.6% | 44.7% | 2.3% | 1.8% | 2.8% | |||
| ethnicity | White British | 47.9% | 43.3% | 52.6% | 3.1% | 2.6% | 3.6% | ||
| White Irish | 47.0% | 38.7% | 55.8% | 3.4% | 2.4% | 4.4% | |||
| Any other white background | 57.1% | 50.1% | 64.4% | 2.7% | 1.9% | 3.5% | |||
| White and Black Caribbean | 57.6% | 47.1% | 68.8% | 2.7% | 1.4% | 3.9% | |||
| White and Black African | 61.3% | 45.6% | 78.9% | 2.6% | 0.8% | 4.5% | |||
| White and Asian | 62.6% | 49.9% | 76.9% | 2.6% | 1.1% | 4.1% | |||
| And other mixed background | 59.6% | 47.6% | 72.0% | 2.5% | 1.2% | 3.9% | |||
| Indian | 64.9% | 57.8% | 72.5% | 2.6% | 1.8% | 3.4% | |||
| Pakistani | 71.8% | 62.3% | 82.0% | 2.8% | 1.7% | 3.9% | |||
| Bangladeshi | 75.3% | 64.0% | 87.9% | 3.4% | 2.2% | 4.7% | |||
| Any other Asian background | 64.3% | 55.4% | 73.5% | 2.5% | 1.4% | 3.5% | |||
| Caribbean | 53.9% | 48.0% | 59.9% | 2.0% | 1.3% | 2.7% | |||
| African | 63.5% | 53.8% | 73.9% | 2.5% | 1.4% | 3.6% | |||
| And other Black background | 65.1% | 55.9% | 74.9% | 3.1% | 2.0% | 4.2% | |||
| Chinese | 74.5% | 60.8% | 89.3% | 2.2% | 0.7% | 3.8% | |||
| Any other ethnic group | 57.8% | 49.0% | 67.3% | 2.3% | 1.3% | 3.4% | |||
| not stated / not given | 53.2% | 45.2% | 61.8% | 3.0% | 2.1% | 4.0% | |||
| deprivation | 1 - most deprived | 52.9% | 47.6% | 58.4% | 3.1% | 2.4% | 3.7% | ||
| 2 | 51.8% | 46.9% | 56.7% | 3.0% | 2.4% | 3.6% | |||
| 3 | 50.9% | 46.1% | 55.7% | 2.9% | 2.4% | 3.5% | |||
| 4 | 51.6% | 46.9% | 56.3% | 3.2% | 2.6% | 3.7% | |||
| 5 | 50.0% | 45.4% | 54.8% | 3.2% | 2.6% | 3.7% | |||
| 6 | 49.4% | 44.6% | 54.2% | 3.0% | 2.4% | 3.5% | |||
| 7 | 49.8% | 44.7% | 55.0% | 2.9% | 2.4% | 3.5% | |||
| 8 | 49.9% | 44.6% | 55.4% | 2.9% | 2.3% | 3.5% | |||
| 9 | 49.9% | 44.9% | 55.0% | 2.9% | 2.3% | 3.5% | |||
| 10 - least deprived | 50.9% | 45.8% | 56.0% | 3.0% | 2.4% | 3.6% | |||
| urbanicity | urban | 51.6% | 46.9% | 56.5% | 3.0% | 2.5% | 3.6% | ||
| rural | 47.9% | 42.9% | 53.0% | 3.1% | 2.5% | 3.7% | |||
| acuity | immediate / very urgent | 50.4% | 43.6% | 57.8% | 1.6% | 0.8% | 2.4% | ||
| urgent | 48.4% | 44.0% | 53.1% | 2.5% | 2.0% | 3.0% | |||
| standard / not urgent | 54.8% | 47.4% | 62.9% | 3.6% | 2.8% | 4.4% | |||
| arrival mode | ambulance | 31.9% | 28.2% | 35.7% | 1.9% | 1.5% | 2.4% | ||
| walk in | 60.3% | 53.5% | 67.6% | 3.5% | 2.7% | 4.3% | |||
| diagnosis | Laceration | 37.3% | 16.5% | 60.9% | 4.5% | 2.0% | 7.3% | ||
| Contusion/abrasion | 66.9% | 53.1% | 82.1% | 4.2% | 2.6% | 5.9% | |||
| Soft tissue inflammation | 51.5% | 43.2% | 60.2% | 4.5% | 3.5% | 5.5% | |||
| Head injury | 55.5% | 46.6% | 64.8% | 3.5% | 2.4% | 4.5% | |||
| Dislocation/fracture/joint injury/amputation | 46.3% | 31.9% | 61.6% | 3.3% | 1.6% | 5.1% | |||
| Sprain/ligament injury | 68.4% | 50.4% | 87.9% | 4.9% | 2.8% | 7.0% | |||
| Muscle/tendon injury | 65.6% | 55.0% | 76.7% | 4.4% | 3.2% | 5.7% | |||
| Burns and scalds | 37.0% | 19.3% | 55.7% | 5.0% | 2.8% | 7.3% | |||
| Foreign body | 36.3% | 21.8% | 51.4% | 4.5% | 2.7% | 6.4% | |||
| Poisoning (including overdose) | 39.7% | 31.1% | 48.6% | 4.1% | 3.0% | 5.2% | |||
| Visceral injury | 35.6% | 19.9% | 52.3% | 3.4% | 1.5% | 5.4% | |||
| Infectious disease | 55.4% | 31.5% | 84.7% | 0.4% | -2.6% | 3.3% | |||
| Local infection | 61.1% | 38.6% | 87.8% | 5.1% | 2.3% | 8.1% | |||
| Septicaemia | 56.7% | 47.6% | 66.5% | 2.4% | 1.3% | 3.5% | |||
| Cardiac conditions | 43.7% | 38.7% | 48.9% | 3.7% | 3.1% | 4.3% | |||
| Cerebro-vascular conditions | 39.0% | 31.9% | 46.4% | 3.6% | 2.7% | 4.4% | |||
| Other vascular conditions | 34.6% | 20.6% | 49.3% | 3.9% | 2.2% | 5.7% | |||
| Haematological conditions | 44.0% | 37.7% | 50.1% | 3.7% | 3.0% | 4.4% | |||
| CNS conditions | 44.9% | 39.1% | 51.1% | 3.0% | 2.2% | 3.7% | |||
| Respiratory conditions | 59.7% | 30.0% | 94.9% | -0.4% | -4.1% | 3.1% | |||
| Gastrointestinal conditions | 43.4% | 38.0% | 48.9% | 3.5% | 2.8% | 4.1% | |||
| Urological conditions | 46.4% | 41.5% | 51.6% | 3.3% | 2.7% | 3.9% | |||
| Obstetric conditions | 54.9% | 32.3% | 81.5% | 3.7% | 1.0% | 6.7% | |||
| Gynaecological conditions | 43.3% | 36.6% | 50.1% | 3.7% | 2.9% | 4.5% | |||
| Endocrinological conditions | 36.2% | 29.3% | 43.4% | 3.4% | 2.5% | 4.2% | |||
| Dermatological conditions | 59.9% | 49.2% | 71.2% | 4.8% | 3.6% | 6.1% | |||
| Allergy | 70.3% | 48.9% | 95.4% | 6.6% | 4.1% | 9.4% | |||
| Facio-maxillary conditions | 19.7% | 6.4% | 33.4% | 3.5% | 1.8% | 5.2% | |||
| ENT conditions | 65.9% | 51.0% | 82.5% | 2.2% | 0.5% | 4.0% | |||
| Psychiatric conditions | 40.4% | 33.5% | 47.7% | 4.0% | 3.1% | 4.8% | |||
| Ophthalmological conditions | 54.0% | 43.5% | 64.9% | 4.8% | 3.6% | 6.1% | |||
| Social problem | 44.9% | 36.8% | 53.4% | 4.4% | 3.4% | 5.3% | |||
| Diagnosis not classifiable | 72.7% | 62.9% | 83.4% | 2.7% | 1.6% | 3.9% | |||
| Nothing abnormal detected | 50.3% | 45.0% | 55.7% | 3.4% | 2.8% | 4.0% | |||
| not known | 60.2% | 47.3% | 74.6% | 1.4% | −0.2% | 3.0% | |||
% step change in ED activity at interruption and % increase in activity per week after interruption.